8-K
filed May 28, 2026, 4:05 PM ET
ticker LAB
CIK 0001162194
other material
confidence high
sentiment neutral
materiality 0.40
Standard BioTools approves severance plans for CEO, CFO, and CBO through 2028
STANDARD BIOTOOLS INC.
- 2026 Severance Plan for CFO Alex Kim and CBO Sean Mackay: outside COC, 12 months salary, prorated bonus, COBRA subsidy, equity acceleration if terminated by Aug 27, 2026.
- During COC: non-CEOs receive 150% of salary plus target bonus lump sum, 18 months COBRA, and full equity vesting.
- CEO Michael Egholm covered under 2023 Severance Plan: outside COC, 200% salary over 24 months, 12 months COBRA, outplacement.
- During COC: CEO gets 250% of salary plus bonus lump sum, 30 months COBRA, and full equity vesting.
- 2026 Severance Plan supersedes the 2024 plan; both plans expire August 4, 2028.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-245181
- form_type
- 8-K
- ticker
- LAB
- cik
- 0001162194
- company_name
- STANDARD BIOTOOLS INC.
- filed_at
- 2026-05-28T20:05:17+00:00
- discovered_at
- 2026-05-28T20:07:00.324691+00:00
- generated_at
- 2026-05-28T21:21:21.199443+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-245181
- json_url
- https://secwatch.observer/filing/0001193125-26-245181.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-245181.md
- text_url
- https://secwatch.observer/filing/0001193125-26-245181.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/0001193125-26-245181-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/lab-20260521.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BRANDYWINE OPERATING PARTNERSHIP, L.P.
Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP
BRANDYWINE OPERATING PARTNERSHIP, L.P.
June 1, 2026, 4:30 PM ET
other_material
Items 1.01, 2.03, 5.02, 5.07, 9.01
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SIRI
Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors
SIRIUS XM HOLDINGS INC.
June 1, 2026, 4:28 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ESPR
Esperion shareholders approve 7M-share increase to 2022 equity incentive plan
Esperion Therapeutics, Inc.
June 1, 2026, 4:22 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.02, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
EMYB
Embassy Bancorp expands stock repurchase program by additional $5M
Embassy Bancorp, Inc.
June 1, 2026, 4:37 PM ET
other_material
Items 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTXR
Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned
Citius Pharmaceuticals, Inc.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
RMR
RMR highlights $37B AUM, 40%+ EBITDA margins, and $120M liquidity in investor presentation
RMR GROUP INC.
June 1, 2026, 4:11 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.